...
首页> 外文期刊>Medicine. >Ultrasound-guided intra-articular injection of hyaluronic acid and ketorolac for osteoarthritis of the carpometacarpal joint of the thumb: A retrospective comparative study
【24h】

Ultrasound-guided intra-articular injection of hyaluronic acid and ketorolac for osteoarthritis of the carpometacarpal joint of the thumb: A retrospective comparative study

机译:超声引导的透明质酸内注射透明质酸和Ketorolac对拇指毛细血管关节的骨关节炎:回顾性比较研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Intra-articular hyaluronic acid (HA) is widely used to treat symptomatic osteoarthritis (OA) in the carpometacarpal joint (CMCJ) of the thumb. However, although apparently effective and relatively safe, intra-articular HA injections act relatively slowly. Therefore, a nonsteroidal anti-inflammatory drug could be added for more prompt pain relief. The aim of this study was to compare the efficacy and safety of ultrasound (US)-guided intra-articular injection of HA and ketorolac with that of HA alone in patients with OA of the CMCJ of the thumb. Seventy-four patients identified by chart review to have a diagnosis of OA of the CMCJ of the thumb received either a US-guided intra-articular injection of 0.5 mL of sodium hyaluronate and 0.5 mL of ketorolac (n = 38) or 0.5 mL of sodium hyaluronate and 0.5 mL of saline (n = 36). Disabilities of the arm, shoulder, and hand (DASH) and verbal numeric scale (VNS) pain scores were recorded before and 1, 3, and 6 months after injection. Univariable analyses (using the chi-squared test) and multiple logistic regression analysis were performed to evaluate the relationship between potential predictors of the outcome (treatment allocation, patient age and sex, duration of pain, and Eaton–Littler classification) and therapeutic effects. The DASH and VNS scores were improved at 1, 3, and 6 months postinjection in both groups. The onset of pain relief was significantly more rapid (at 1 month) after the injection containing HA and ketorolac than after the injection containing HA alone. In 55.3% of cases, pain and function were improved postinjection compared with baseline and remained so for up to 6 months. The success rate was not significantly different between the assessments at 1, 3, and 6 months, and the univariable analyses did not identify any statistically significant potential predictors of the outcome. Multiple logistic regression analysis did not identify any independent predictors of a successful outcome at midterm follow-up. The onset of analgesic action was more rapid after an injection containing HA and ketorolac than after 1 containing HA alone in patients with OA of the CMCJ of the thumb. There were no serious complications.
机译:关节内透明质酸(HA)广泛用于治疗拇指的痈术接头(CMCJ)中的症状骨关节炎(OA)。然而,虽然显然有效且相对安全,但关节内的HA注射相对缓慢。因此,可以添加非甾体抗炎药以进行更迅速的疼痛缓解。本研究的目的是比较超声(美国) - 颈内注射HA和Ketorolac的疗效和安全性,其中HA独自在拇指CMCJ的OA患者中。通过图表审查确定的七十四名患者对拇指的CMCJ的OA诊断接受了US引导的透明质酸钠和0.5ml酮烷基(n = 38)或0.5ml透明质酸钠和0.5ml盐水(n = 36)。手臂,肩部和手(跳线)和口头数刻度(VNS)疼痛评分的残疾被记录在注射后1,3和6个月。不稳定的分析(使用Chi方向测试)和多元逻辑回归分析进行了评估结果的潜在预测因子之间的关系(治疗分配,患者年龄和性别,疼痛持续时间和伊顿 - Littler分类)和治疗效果。在两个组中发布的1,3和6个月,延迟和VNS分数得到改善。疼痛缓解的发作在注射后含有HA和Ketorolac的注射后显着更快(在1个月)比单独含有的注射液之后。在55.3%的病例中,与基线相比,疼痛和功能得到改善,并且保持长达6个月。在1,3和6个月的评估之间的成功率并没有显着差异,并且单一的分析并未确定结果的任何统计上大量的潜在预测因子。多个逻辑回归分析未识别中期随访中成功结果的任何独立预测因子。在含有HA和Ketorolac的注射后比单独含有HA的1次拇指的患者,镇痛作用的发作更快。没有严重的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号